Categories: All postsAnalysts

Paradigm raises price target on Sabio to $1.50

Following the company’s fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has raised his price target on Sabio Holdings (Sabio Holdings Stock Quote, Chart, News, Analysts, Financials TSXV:SBIO).

On March 17, SBIO reported its Q4 and fiscal 2024 results. In the fourth quarter, the company posted Adjusted EBITDA of (All figures USD) $2.8-million on revenue of $18.3-million, a topline that was up 44%, year-over-year.

“Strong revenue growth, a leaner cost structure, and a strengthened balance sheet are enabling us to make growth-driving investments,” CEO Aziz Rahimtoola said. “Our recently launched performance marketing solutions enable brands to track direct impact on consumer behavior, capitalizing on the App Science™ platform’s unique AI-capabilities and rich combination of mobile device and ad-supported TV streaming data. In addition, our new App Science-powered programmatic offerings provide clients with greater control while making efficient use of our team. Combined with early traction in our international business and Creator TV’s focus on the valuable Gen Z demographic, Sabio believes it is well positioned to continue exceeding industry growth rates while tightening Adjusted EBITDA1 margins. As ad-supported streaming continues its rapid uptake, we’re looking forward to producing extraordinary results for a growing number of the world’s top brands.”

Rosenberg assessed the fourth quarter results.

“Sabio reported positive Q4 results that were at the top end of preliminary guidance,” he wrote. “The company’s positioning in political and advocacy spending was a benefit and investment in international markets is showing early signs of success. Sabio is achieving profitability targets and seeing strong operating momentum into 2025. Management expects doubled digit growth to continue in 2025.”

In a research update to clients March 18, the analyst maintained his “Buy” rating and raised his price target on the stock from $1.25 to $1.50, implying a return of 124% at the time of publication.

The analyst thinks the company will post Adjusted EBITDA of $4.4-million on revenue of $54.3-million in fiscal 2025. He expects those numbers will improve to Adjusted EBITDA of $4.7-million on a topline of $58.8-million in fiscal 2026.

“We value Sabio using a 1.8x EV/net revenue multiple on our 2026 forecast,” Rosenberg added. “This results in our new target price of C$1.50 (C$1.25 prior). Our comparable peers consist of AdTech players who trade at a median of 2.8x 2025e net revenue while Sabio currently trades at 0.7x. We think Sabio is poised for a strong 2025. While the company benefited from strong political spending this quarter, the core business continues to trend well. We continue to see Sabio growing ahead of industry rates given a differentiated CTV offering that is gaining wallet share with marquee clients.”

Disclosure: Sabio is an annual sponsor of Cantech Letter

Tagged with: sbio
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

National Bank trims price target on Rogers Communications

National Bank Financial analyst Adam Shine says Rogers Communications’ (Rogers Communications Stock Quote, Chart, News, Analysts, Financials TSX:RCI.B) deal to… [Read More]

9 hours ago

Custom Health Holdings is a buy, this analyst says

Stifel analyst Justin Keywood says Custom Health Holdings (Custom Health Holdings Stock Quote, Chart, News, Analysts, Financials TSX:CHLT) is building… [Read More]

10 hours ago

Anthropic lease will generate billions for TeraWulf, this analyst says

ATB Capital Markets analyst Martin Toner says TeraWulf’s (TeraWulf Stock Quote, Chart, News, Analysts, Financials NASDAQ:WULF) new Anthropic lease and… [Read More]

10 hours ago

Trulieve’s medical business is “a force”, this analyst says

Roth Capital Partners analyst Bill Kirk says Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials NYSE:TRUL)  remains a… [Read More]

10 hours ago

Intermap Technologies: Buy, Sell or Hold?

Beacon Securities analyst Russell Stanley says Intermap Technologies’ (Intermap Technologies Stock Quote, Chart, News, Analysts, Financials TSX:IMP) new AI-enabled orthorectification… [Read More]

1 day ago

Here’s the bull case for Microsoft

Murray Wealth Group senior portfolio manager Michael Hakes says Microsoft’s (Microsoft Stock Quote, Chart, News, Analysts, Financials NASDAQ:MSFT) bull case… [Read More]

1 day ago